MCRB(MCRB)
MCRB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $13M | $358,000 | $358,000 | $249,644 |
| Low | $9M | $243,180 | $243,180 | $169,576 |
| High | $17M | $472,819 | $472,819 | $329,711 |
| EBITDA Avg | $9M | $258,377 | $258,377 | $180,174 |
| Low | $6M | $175,509 | $175,509 | $122,387 |
| High | $12M | $341,245 | $341,245 | $237,960 |
| EBIT Avg | $9M | $255,439 | $255,439 | $178,125 |
| Low | $6M | $173,513 | $173,513 | $120,995 |
| High | $12M | $337,364 | $337,364 | $235,254 |
| Net Income Avg | $-81M | $-58M | $-103M | $-78M |
| Low | $-94M | $-83M | $-143M | $-111M |
| High | $-39M | $-34M | $-59M | $-46M |
| EPS Avg | $-7.51 | $-6.58 | $-11.41 | $-8.80 |
| Low | $-10.65 | $-9.32 | $-16.17 | $-12.47 |
| High | $-4.38 | $-3.83 | $-6.65 | $-5.13 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $13M | $13M |
| Low | $13M | $13M |
| High | $13M | $13M |
| EBITDA Avg | $9M | $9M |
| Low | $9M | $9M |
| High | $9M | $9M |
| EBIT Avg | $9M | $9M |
| Low | $9M | $9M |
| High | $9M | $9M |
| Net Income Avg | $-16M | $-16M |
| Low | $-16M | $-16M |
| High | $-16M | $-16M |
| EPS Avg | $-1.64 | $-1.63 |
| Low | $-1.64 | $-1.63 |
| High | $-1.64 | $-1.63 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |